Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis China Revenue Share by Year
China Revenue Share (%) (%)
Novartis China Revenue Share: 8.0% in FY2025, unchanged from a year earlier.
Latest, FY2025
8.0%
Period ended Dec 31, 2025
Change on a year earlier
0.0 pts
8.0% in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | China Revenue Share (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.0% | 0.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 8.0% | +1.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 7.0% | 0.0 pts | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 7.0% | 0.0 pts | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2021 | Dec 31, 2021 | 7.0% | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Cite this data
StockData. (2026). Novartis China Revenue Share (%), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-country-china-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.